See the DrugPatentWatch profile for kerendia
Is a Generic Version of Kerendia Available?
Currently, there is no generic version of Kerendia (finerenone) available on the market. This means that the only approved and available form of the drug is the brand-name product [1].
When Might Generic Kerendia Become Available?
The availability of generic versions of a medication typically depends on the expiration of patents and any other market exclusivities held by the brand-name manufacturer. Information on the specific patent landscape for Kerendia can be found on resources like DrugPatentWatch.com [2]. The development and approval process for a generic drug also takes time after patent expiry.
What is Kerendia Used For?
Kerendia is a medication prescribed to reduce the risk of sustained estimated glomerular filtration rate decline, kidney disease hospitalization, cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with chronic kidney disease associated with type 2 diabetes [1].
How Does Kerendia Work?
Kerendia is a non-steroidal selective mineralocorticoid receptor antagonist [1]. It works by blocking the damaging effects of excess mineralocorticoid receptor stimulation in the kidneys and heart, which can be exacerbated by conditions like type 2 diabetes [3].
Who Manufactures Kerendia?
Kerendia is manufactured by Bayer [1].
What Are the Potential Side Effects of Kerendia?
Common side effects associated with Kerendia include hyperkalemia (high potassium levels), hypotension (low blood pressure), and diarrhea [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are There Alternatives to Kerendia?
Treatment for chronic kidney disease associated with type 2 diabetes often involves a multi-faceted approach. This can include managing blood sugar levels, blood pressure control, and dietary modifications. Other medications may also be used to manage kidney disease, depending on the individual patient's condition [4].
What Is the Pricing of Kerendia?
As a brand-name medication without generic alternatives, Kerendia's pricing is set by the manufacturer. Pricing can vary based on insurance coverage, pharmacy, and geographic location. Patients may be able to find savings programs or coupons offered by the manufacturer [1].
What Are the Regulatory Approvals for Kerendia?
Kerendia has received approval from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for its indicated uses [1].
What Clinical Data Supports Kerendia's Use?
The efficacy and safety of Kerendia have been demonstrated in clinical trials, including the FIDELIO-DKD and FIGARO-DKD studies, which formed the basis for its regulatory approvals [1][3].
**Sources:
[1] Bayer, Kerendia (finerenone) Prescribing Information.
[2] DrugPatentWatch.com.
[3] Heers, H., et al. (2022). Finerenone: A Novel Nonsteroidal Mineralocorticoid Receptor Antagonist for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes. *Journal of Cardiovascular Pharmacology and Therapeutics, 27.
[4] National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Chronic Kidney Disease (CKD).